The recQ-like helicase BLM interacts directly with topoisomerase IIa to regulate chromosome breakage in human cells. We demonstrate that a phosphosite tri-serine cluster (S577/S579/S580) within the BLM topoisomerase IIa-interaction region is required for this function. Enzymatic activities of BLM and topoisomerase IIa are reciprocally stimulated in vitro by ten-fold for topoisomerase IIa decatenation/relaxation activity and three-fold for BLM unwinding of forked DNA duplex substrates. A BLM transgene encoding alanine substitutions of the tri-serine cluster in BLM À/À transfected cells increases micronuclei, DNA double strand breaks and anaphase ultra-fine bridges (UFBs), and decreases cellular co-localization of BLM with topoisomerase IIa. In vitro, these substitutions significantly reduce the topoisomerase IIaÀmediated stimulation of BLM unwinding of forked DNA duplexes. Substitution of the tri-serine cluster with aspartic acids to mimic serine phosphorylation reverses these effects in vitro and in vivo. Our findings implicate the modification of this BLM tri-serine cluster in regulating chromosomal stability.
Introduction
Bloom's syndrome (BS), a genetically determined human chromosome breakage disorder, is caused by loss of function mutations of the recQ-like helicase BLM (1) (2) (3) . Cells without BLM are characterized by elevated intra-and inter-chromosome recombination, and spontaneous chromosome breakage. Clinical characteristics of BS invariably include short stature, male infertility and an increased risk of cancer. The BLM helicase is an ATPdependent, 3'-5' structure-specific helicase vital for DNA replication, transcription and repair (4) (5) (6) . BLM maintains normal DNA repair functions through its participation in homologous recombination and non-homologous end joining although the exact mechanisms by which it prevents or responds to chromosome breakage are less understood (7) (8) (9) .
BLM interacts directly with type I topoisomerases (topoisomerase I and topoisomerase IIIa), and type II topoisomerases (topoisomerase IIa) (5, 6, (10) (11) (12) (13) (14) . Topoisomerases resolve DNA topological constraints arising from strand separation during replication, replication-repair, recombination and transcription. The most studied complex of BLM with type I topoisomerases is the BTRR complex that consists of BLM, topoisomerase IIIa and the RMI proteins RMI1 and RMI2 and participates in resolving linked intermediates during replication and recombination (12) .
BLM interacts with topoisomerase IIIa primarily within its Nterminus (amino acids 1-212 of 1417), although an additional region within the extreme C-terminus (amino acids 1266-1417) has been reported (10) . BLM also interacts with topoisomerase I to resolve RNA-DNA hybrids during ribosomal DNA transcription (5, 6) . The interaction of BLM with topoisomerase I reciprocally stimulates respective biochemical activities and most likely facilitates RNA polymerase I transcription in the nucleolus (6) . BLM interaction with topoisomerase I is facilitated by amino acids 1332-1349, that also overlap nuclear localization sequences (6, 13) .
BLM interacts with topoisomerase IIa via amino acids 489-587 (11) . This interaction is required for the correction of chromosome breakage, measured by micronuclei formation in transfection experiments in cell lines lacking BLM. Additionally, topoisomerase IIa stimulates BLM helicase activity in vitro using DNA substrates mimicking early homologous recombination structures (11) . BLM, in conjunction with the Plk1-interacting checkpoint helicase (PICH), plays a role in the resolution of centromeric chromatin and the recruitment of active topoisomerase IIa to the centromere (12, 15, 16) . Cell lines lacking BLM display excessive numbers of anaphase bridges and lagging chromosomes suggesting a reduced or dysfunctional localization of topoisomerase IIa to the centromere during mitosis (17) .
BLM localization and cellular functions are regulated by post-translational modifications in response to cellular stress. These modifications (phosphorylation, ubiquitination and sumoylation) may alter different aspects of its functions, stability, localization to damaged DNA or to PML bodies, and its association with other proteins (18) . BLM threonine 99 and 122 are phosphorylated after replicative stress (19, 20) ; phosphorylation of threonine 99 alters the interaction of BLM with topoisomerase III and PML in vivo (21) . CHK1 phosphorylation of BLM serine 646 decreases after DNA damage to promote BLM localization to sites of damaged DNA (22, 23) . BLM also localizes to a class of DAPI-negative/histone-negative anaphase bridges known as ultra-fine bridges (UFBs), as does the Plk1-interacting checkpoint helicase PICH (24, 25) . UFBs resemble fine, thread-like structures and subsequently are classified into three subtypes dependent on their chromosome 'anchorage' origin: telomere/ T-UFB, centromere/C-UFB or fragile site/FS-UFB (16, 26, 27) . These subtypes differ in the proteins that mark their ends: FANCD2/ FANCI localizes to ends of FS-UFBs while HEC1, an outer kinetochore marker, localizes to C-UFBs (18, 28) . The DNA structures found within UFBs are not precisely defined but may represent incompletely replicated DNA, hemicatenanes or catenanes. In the G2/M-phase cell cycle transition, sister chromatids are typically connected by hemicatenanes and are catenated at the centromere (29, 30) . Topoisomerase IIa decatenates these structures to resolve anaphase bridges or UFBs, and prevent chromosome breakage and/or chromosome nondisjunction (14, 31) . PICH and BLM may collaborate to keep UFBs histone-negative, thus allowing topoisomerase IIa to bind and resolve these aberrant DNA structures (15, 16, 32) . BLM is capable of dissolving hemicatenates between sister chromatids to form non-crossover products (33) . Currently, little is known about the regulation and biochemical implications of the BLM/topoisomerase IIa interactions at these structures or at other sites of damaged DNA.
Here, we identify a novel phosphosite tri-serine cluster (S577/S579/S580) within the topoisomerase IIa-interaction domain of BLM that regulates the interaction of BLM and topoisomerase IIa and its subsequent functions in reducing chromosome breakage. Biochemical assays demonstrate that BLM and topoisomerase IIa reciprocally stimulate the enzymatic activity of the other. The increase in BLM activity by topoisomerase IIa is dependent upon the tri-serine cluster, as alanine substitution reduces this stimulation; aspartic acid (phosphomimic) substitution is similar to that observed with wild-type BLM. In vivo assays monitoring BLM-topoisomerase IIa colocalization, chromosome breakage and UFB formation show that alanine substitution of the serine cluster reduces BLMtopoisomerase IIa co-localization and increases chromosome damage; aspartic acid substitution maintains co-localization and chromosome breakage levels that are similar to wild type BLM. Our studies implicate the tri-serine cluster of BLM in resolving UFBs and reducing subsequent chromosome breakage.
Results

Interaction of BLM and topoisomerase IIa results in reciprocal stimulation of respective biochemical activities
Our previously published work has shown that BLM interacts with topoisomerase IIa via amino acids 489-587 of BLM and that this region is required for topoisomerase IIa-mediated stimulation of BLM helicase activity using short duplex substrates with a 3' overhang and bubble substrates (11) . The experiments presented here were designed to characterize topoisomerase IIa-BLM functions reciprocally. We first determined helicase reaction kinetics and initial rates of unwinding with a forked DNA substrate to model a replication fork in the presence or absence of topoisomerase IIa. The substrates and products of the reaction were resolved on a 10% native PAGE, quantified and the percentage of substrate unwound plotted as a function of time ( Fig. 1A and B left panels). Results demonstrate that BLM unwinding follows Michaelis-Menten kinetics and that topoisomerase IIa increases the reaction kinetics with a 3.3-fold increase in the maximum substrate unwound (Fig. 1A left panel, Supplementary Material, Figs S1 and S3A), as well as with a 2.6-fold increase in the initial unwinding rate of BLM (Fig. 1B left  panel) . Topoisomerase IIa alone is unable to unwind the substrate (Supplementary Material, Fig. S1 ).
Disentanglement of chromatids during cell division is catalyzed by topoisomerase II. This activity can be biochemically measured in vitro by the ability of an enzyme to decatenate kinetoplast DNA (kDNA) or relax supercoiled DNA. In order to assess if and how the catalytic functions of topoisomerase IIa are affected by BLM, these two activities were monitored in the absence or presence of purified BLM (Fig. 2) . BLM alone is unable to decatenate kDNA or relax supercoiled DNA. The concentration of topoisomerase IIa was reduced to observe minimal decatenation of kDNA ( Fig. 2A) or relaxation of supercoiled DNA (Fig. 2C) . The effects of BLM on the reactions were then monitored. BLM stimulated topoisomerase IIa decatenation activity nearly 10-fold ( Fig. 2A and B) . Likewise, BLM stimulated the relaxation activity of topoisomerase IIa (Fig. 2C) . These results highlight the reciprocal effects of BLM-topoisomerase IIa interaction on enzymatic functions.
A tri-serine cluster S577/S579/S580 within the topoisomerase IIainteraction domain of BLM is critical for topoisomerase IIa-mediated stimulation of BLM helicase activity The interaction between BLM and topoisomerase IIa peaks in mitosis, as shown previously by co-localization and coimmunoprecipitation (11, 34) . BLM is also heavily phosphorylated in M-phase of the cell cycle (18, 34) . Lastly, ongoing experiments with in vitro expressed and purified BLM protein show BLM mobility shifts suggestive of phosphorylation (Supplementary Material, Fig. 2A ). Therefore, we used sequence analysis of the topoisomerase IIa-interaction domain of BLM (amino acids 489-587) to identify five serines organized in two clusters: S517 and S518 in cluster one (C1) and S577, S579 and S580 in cluster two (C2). These serines were evaluated as phosphorylation targets by further informatic analyses and high-resolution mass spectrometry (Supplementary Material, Fig. S2B and C) . In order to determine whether these serines contribute to BLM function, serines in each cluster were replaced by either alanine (BLM-C1A, BLM-C2A) or aspartic acid (BLM-C1D, BLM-C2D) using in vitro mutagenesis. Vectors with BLM modifications were generated for protein expression and transfection experiments, and used for biochemical and cytological analyses.
BLM proteins (BLM-C1A, BLM-C1D, BLM-C2A and BLM-C2D) were purified to homogeneity. Protein yields and helicase activities of the BLM proteins were similar to one another (Materials and Methods). Proteins were tested for helicase activity in the presence or absence of topoisomerase IIa ( Fig. 1 middle and right panels, Supplementary Material, Fig. S3B ). Cluster C1 mutations had no effect on the ability of topoisomerase IIa to stimulate BLM helicase activity (data not shown). However, cluster C2 mutations had a differential effect on the ability of topoisomerase IIa to stimulate BLM helicase activity. BLM-C2D was stimulated by topoisomerase IIa with a 3.4-fold increase in the maximum substrate unwound ( . We also tested the ability of the mutants to modulate TOP2A decatenation activity. We did not see a significant difference in the rate of stimulation between the two mutants or in contrast to wild-type but cannot rule out subtle changes due to the fast kinetics of TOP2A stimulation and the rapid jump in decatenation rates between 3 and 5 min (Fig. 2) . Coimmunoprecipitation of wild-type BLM or its mutants (C1 or C2) with recombinant topoisomerase IIa also did not reveal significant differences (Supplementary Material, Fig. S2D ). However, enzymatic results for BLM helicase activity support the conclusion that the C2 serine cluster plays a critical role in regulating BLM function by topoisomerase IIa.
The tri-serine cluster S577/S579/S580 of BLM is critical for correction of elevated chromosome breakage in cells without BLM Our biochemical results suggest that serine modifications of BLM at S577, S579 and S580, and the reciprocal enzymatic effects of BLM and topoisomerase IIa may have functional implications for DNA repair. As the interaction of BLM and topoisomerase IIa changes enzymatic efficiency, we asked how it may affect the elevated chromosome breakage characteristic of cells lacking the BLM helicase (11) . Micronuclei assays were used to assess whether the biochemical differences between the BLM cluster mutants translated to a cellular phenotype, as these are one of the most sensitive methods for detecting cellular chromosome damage (35) . Numerous reports have shown high levels of micronuclei in vivo in those with BS (11, 22, 36, 37) . Micronuclei arise from unrepaired DNA double-stranded breaks that generate acentric chromosome fragments that fail to be shown in the graph on the right (9.2% decatenated kDNA/min in the presence of BLM; 0.76% decatenated kDNA/min in the absence of BLM). (C) Topoisomerase IIa relaxation activity with 3kbp supercoiled DNA (RFI) was monitored using 3nM TOP2A in the absence or presence of 27nM BLM. Reactions were stopped, products separated on a 1% agarose gel without ethidium bromide, stained with 0.5mg/ml ethidium bromide for 30 min and topomers monitored by UV. A representative gel is shown. The graph shows relaxation (%) by topoisomerase IIa in the absence or presence of BLM, and by BLM alone; inset shows a representative gel. incorporated in daughter nuclei during mitosis (35, 38) . BLM protein without the topoisomerase IIa-interaction region (D489-587) fails to reduce the number of micronuclei in the BLM À/À cell line GM08505 (11) . BLM-C1 and -C2 mutants were tagged with GFP and tested for their ability to reduce the elevated number of micronuclei in GM08505 (BLM À/À ) cells. Cells were transfected with pEGFP-empty, pEGFP-BLM, pEGFP-BLM-D795A (helicase-dead mutant), pEGFP-BLM-D489-587, Cluster 1 mutants (pEGFP-BLM-C1A, pEGFP-BLM-C1D) or Cluster 2 mutants (pEGFP-BLM-C2A or pEGFP-BLM-C2D) and examined for micronuclei (Fig. 3A) .
Transfection Fig. S4 ). Threonine 581 was also identified as a potential phosphorylation site by the in silico prediction programs (Supplementary Material, Fig. S2B ). Interestingly, this site is four amino acids C-terminal to serine 577, a site predicted to be modified by GSK3 kinase, defining serine 581 as a potential pre-phosphorylation priming site (39) . Micronuclei studies with cells transfected with pEGFP-BLM577A, pEGFP-BLM577D, pEGFP-BLM581A or pEGFP-BLM581D did not differ from wild-type BLM in correction of chromosome breakage (Supplementary Material, Fig. S4 ). In total, these results pinpoint the three serines within cluster 2 as important for reducing chromosome damage and imply that phosphorylation of all three serines may be the likely modulator.
The BLM topoisomerase IIa-interaction domain and the S577/S579/ S580 tri-serine cluster are required for efficient UFB resolution BLM localizes to a class of DAPI-negative/histone-negative anaphase bridges known as ultra-fine bridges (UFBs) (18) . As BLM À/À cells and those treated with topoisomerase II inhibitors exhibit high numbers of UFBs, we examined the localization of BLM-C2A and -C2D to UFBs. BLM À/À cells were transfected with pEGFP-BLM, pEGFP-BLM-D795A (helicase-dead mutant), pEGFP-BLM-D489-587, pEGFP-BLM-C2A or pEGFP-BLM-C2D, and evaluated for UFBs. BLM phospho-mutants BLM-C2A and BLM-C2D localize to UFBs, as do BLM, BLM-D489-587 and BLM-D795A proteins (Fig. 3B, top Fig. S5 ). These data suggest that the BLM topoisomerase IIa-interaction domain and the tri-serine cluster within it are vital for the resolution of UFBs, but are less relevant for anaphase bridges. Although BLM localizes to UFBs, we were unable to demonstrate the localization of topoisomerase IIa to UFBs. Topoisomerase IIa was visible at DAPI-positive anaphase bridges in both normal and BLM À/À cells, suggesting that its localization to anaphase bridges is BLM-independent (Supplementary Material, Fig. S6 ).
The tri-serine cluster S577/S579/S580 of BLM is critical for BLM colocalization with topoisomerase IIa BLM and topoisomerase IIa are minimally expressed during G1-, increase in S-and peak in G2/M-phases of the cell cycle (34, 40) . Their co-localization is also most prominent in M-phase (11, 34) . Co-localization of BLM-C2A and BLM-C2D with topoisomerase IIa was examined during G1/S and G2/M (Fig. 4A-C) . BLM À/À cells were transfected with pEGFP-BLM, pEGFP-BLM-D489-587, pEGFP-BLM-C2A or pEGFP-BLM-C2D. Cells were synchronized using a double-thymidine block and collected 4-h post-release to obtain cells in G1/S or 11-h plus colcemid treatment to obtain cells in G2/M. FACS analysis confirmed synchronization (Fig. 4C) .
Immunofluorescence studies demonstrated that BLM-C2A is significantly reduced in its co-localization with topoisomerase IIa in G2/M-phase (18% in cells expressing BLM-C2A compared with 50% in cells expressing wild-type BLM, p 0.0001) (Fig. 4B) . The reduction in co-localization of topoisomerase IIa and BLM-C2A is comparable to that in cells expressing the topoisomerase IIa-interaction domain deletion mutant BLM-D489-587 in G2/M (10% co-localization). In comparison, cells expressing the phospho-mimic BLM-C2D retain the ability to co-localize BLM-C2D with topoisomerase IIa similarly to cells expressing wildtype BLM (54% in cells expressing BLM-C2D compared with 50% in cells expressing BLM). Localization of wild type and mutant BLM proteins to PML bodies and the nucleolus was examined in order to rule out alteration of cellular localization in considering the effects of serine mutations. BLM-C1A, BLM-C1D, BLM-C2A and BLM-C2D localize to PML bodies and the nucleolus similarly to wild-type BLM (Supplementary Material, Fig. S7 ). These data suggest that modification of serines 577, 579 and 580 of BLM alters BLM and topoisomerase IIa co-localization in vivo.
Discussion
This study has characterized a novel serine cluster (serines 577, 579 and 580) within the topoisomerase IIa-interaction domain of BLM that is necessary for topoisomerase IIa-mediated stimulation of BLM helicase activity in vitro, G2/M-phase cell cyclespecific co-localization with topoisomerase IIa in vivo and maintenance of low levels of chromosome breakage IIa as measured by UFBs and micronuclei formation (Figs 1-4) . Phosphomimetic aspartic acid substitutions of all three serines within the cluster are compatible with these functions, while non-phosphorylatable alanine substitutions are not. In contrast, single and double mutants (alanine or aspartic acid substitutions) of each serine within this cluster behaved similarly to wild-type BLM (Supplementary Material, Fig. S4 ), suggesting that this is a functional cluster of three serines (577/579/580). Decreased co-localization with topoisomerase IIa, and increased UFBs and chromosome breakage occurs in cells transfected with alanine-substituted pEGFP-BLM-C2A. In comparison, cells transfected with the aspartate-substituted, pEGFP-BLM-C2D or wild-type pEGFP-BLM are similar in co-localization of BLM with topoisomerase IIa, UFBs and levels of chromosome breakage. Phosphosite clusters have been hypothesized to play a functional role in regulating a robust cellular response to phosphorylation, with specific phosphosite combinations determining the rate and duration of various biological responses (41, 42) . Our experiments argue for expanding the approach of studying single amino acids when evaluating phosphorylationdependent processes. Our in vitro and cell culture experiments suggest that phosphorylation of the BLM 577/579/580 cluster could facilitate DNA damage repair, likely through its interaction with topoisomerase IIa. Mass-spectrometry approaches to identify modification of these BLM serines were inconsistent most likely due to difficulties in identifying tandem phosphorylation sites, the acidic nature of this protein region and an inopportune trypsin cleavage site.
BLM forms complexes with several protein partners critical for resolving DNA damage. Similar to our previous studies with topoisomerase I, the interaction of BLM with topoisomerase IIa results in the reciprocal stimulation of the respective protein activities (Figs 1 and 2) (6) . Their interaction increases the rate of DNA unwinding that is reflected in its total unwinding activity ( Fig. 1) and support earlier observations that BLM by itself is a weakly processive helicase with enzymatic activity modulated through its interaction with other proteins to resolve chromosome damage during replication and recombination (6, 9, 13, (43) (44) (45) (46) (47) . Biochemical experiments demonstrate functional differences in the ability of topoisomerase IIa to stimulate BLM proteins with modifications of the tri-serine cluster; these data correlate with the in vivo studies of micronuclei, DNA damage and UFB.
The cellular endpoints of our experiments (co-localization of BLM with TOP2A, micronuclei recovery and UFB formation) suggest that BLM-C2D behaves similarly to wild-type BLM and that BLM-C2A does not. The endpoints of the biochemical assays also suggest that BLM-C2D behaves similarly to wild-type BLM in helicase stimulation by TOP2A and that BLM-C2A does not. These data support the hypothesis that there is a difference in the ability of the two proteins to functionally interact that depends on the modification of these three serines within the TOP2A-interaction domain of BLM. Two other experimental approaches, co-immunopreciptation (co-IP) of BLM and TOP2A, and decatenation assays, were unable to distinguish between C2D and C2A isoforms of BLM in comparison to wild-type BLM. The negative results from these two assays may be related to the experimental constraints of each approach: both co-IP and decatenation assays were performed with excess protein concentrations. Therefore, any subtle differences in the ability of the BLM isoforms to interact with TOP2A could not be assessed. Our attempts to calculate the apparent interaction coefficient (K D ) in vitro were unsuccessful due to variability in the antibody avidity for TOP2A and/or BLM, precluding quantitative analyses. Likewise, the spike in rate of decatenation by TOP2A in the presence of BLM was impossible to slow down with dilutions of protein concentrations. Our results are consistent with the conclusion that the alanine, but not aspartic, substitutions cause a functional defect (in helicase activity stimulation) and perhaps subtle differences in physical interaction with TOP2A that are not detectable in vitro are detectable in vivo, and reflected best in the cellular experiments. It is plausible that the TOP2A-interaction region may not be defined solely by the three amino acid cluster and that this may be contributing to the lack of strong in vitro findings. Our previously published study demonstrated that the interaction domain consists of 99 amino acids (489-587). As explained in Supplementary Material, Fig.  S2B , there are several predicted phosphorylation sites that could potentially influence the interaction between TOP2A and BLM. Thus, mutation of S577, S579 and S580 do not necessarily result in an all-or-nothing effect in controlling direct physical interaction, although it clearly affects some biological endpoints measured in our study. It is possible that BLM-TOP2A foci involve other proteins that may be affected by the C2A mutation. The observation of foci with wild-type BLM and BLM-C2D, but not with BLM-C2A, does not necessarily prove a direct physical interaction, as it may also require other proteins to facilitate foci assembly. However, the absence of foci does correlate with the impaired ability of the C2A helicase to be stimulated by TOP2A.
Ultra-fine anaphase bridges (UFBs) are recently discovered histone-negative, DAPI-negative chromatin bridges seen in anaphase due to residual problems in DNA replication or decatenation. UFBs can be centromeric, non-centromeric (at fragile sites) or telomeric in nature, and are reflective of the aberrant (e.g. late-replicating/recombination intermediates) or unresolved (e.g. catenanes) DNA structures at these chromosomal locations. It is not yet clear if the DNA structures within UFBs are homogenous or heterogeneous. Consequently, proteins associated with the different UFBs are diverse but reflective of their putative functions in resolving specific structures (15, 16, 20, 26, (48) (49) (50) (51) . Both BLM and topoisomerase IIa are implicated in the resolution of structures associated with UFBs and a deficiency of either results in an increase in UFBs. Such a role is also consistent with their respective enzymatic activities. Our studies do not address the specific nature or origin of UFBs and hence we cannot ascertain the kind of DNA anomalies that exist at these UFBs. However, the data presented here reinforce a role for the tri-serine cluster within the BLM topoisomerase IIa-interaction domain in resolution of structures associated with UFBs. While TOP2A activity is an important factor in UFB formation, especially in the context of centromeric UFBs (where catenanes are the primary 'problem'), it is not the only one: defects in replicative repair can also lead to bridges. Our experiments point to the importance of BLM helicase activity and its stimulation by TOP2A to prevent UFB accumulation. We were unable to see topoisomerase IIa localization to the BLMcontaining UFBs; however, the topoisomerase IIa-interaction domain of BLM and the tri-serine cluster within the domain were critical for the UFB resolution. We speculate that the observed BLM-containing UFBs primarily represent DNA intermediates specific for BLM, enabling its recruitment. The absence of topoisomerase IIa visualization might reflect a rapid turnover of topoisomerase IIa within the BLM-containing UFBs, the absence of structures that enable recruitment and stabilization of topoisomerase IIa, or non-involvement of topoisomerase IIa for resolving the DNA structures in BLM UFBs. Other proteins may be involved in recruiting topoisomerase IIa and/or BLM to UFBs as in centromeric UFBs where TOPBP1 associates with UFBs independently of BLM and recruits topoisomerase IIa by a direct physical association with topoisomerase IIa (51) . DNA structures in centromeric UFBs are DNA catenanes that require TOPBP1 to resolve by recruitment of topoisomerase IIa. BLM is not found in the majority of these UFBs, although a small subset is characterized by partial BLM localization (51) . PICH is also a critical protein in recruiting of BLM to centromeric, fragile-site and telomeric UFBs (15, 16, 26, 32, 48, 50) . Some of these UFBs involve topoisomerase IIIa in association with BLM, RMI1 and RMI2 proteins. Manipulation of the BLM/topoisomerase IIa interaction may make it possible to generate catastrophic genomic instability through very precise targeting of the interaction to enhance the effectiveness of, or replace, some oncolytic chemotherapeutics. Our studies also demonstrate that the investigation of genetically determined chromosome instability in the human can lead to precise mechanistic understanding of how chromosome integrity is maintained.
Materials and Methods
Cell lines and tissue culture 
Mutagenesis
Mutations of the BLM serines to alanine or aspartic acid were generated by using PCR primers with mutations followed by cloning of PCR products into pYES-BLM and peGFP-BLM. Reactions were transformed into DH5a-competent cells. Sequencing of individual plasmids confirmed desired alterations.
Helicase and topoisomerase IIa assays
BLM proteins were expressed and purified as previously described (5, 6, 13 Reactions were terminated in TOP2A stop buffer (1% Sarkosyl, 5% glycerol, 10 mM EDTA); products were resolved on 10% nondenaturing polyacrylamide gels in 1X TBE. Gels were dried, exposed on a phosphorimager plate and analysed by ImageQuant software on a Typhoon phosphorimager. Bands were quantified, amount of substrate unwound calculated (%) and plotted as a function of time as indicated. Plots were fitted to MichaelisMenten kinetics using Kaleidagraph software. Standard deviations were calculated from three to five experiments and two independent protein preparations. TOP2A assays were performed as above using either kinetoplast DNA (to monitor decatenation activity) or supercoiled DNA (to monitor relaxation activity).
Reactions were analysed on 1% agarose gel as described by the manufacturer (TopoGen).
In silico phosphorylation prediction 
Immunoprecipitation
Immunoprecipitations were performed using purified proteins at 4 C. Purified BLM, BLM-C1A, BLM-C1D, BLM-C2A or BLM-C2D was incubated with purified TOP2A (Topogen). Two hours of protein incubation was followed by the addition of an anti-BLM antibody or anti-TOP2A antibody and an overnight incubation of the protein-antibody mixture. Protein A/G beads were used to immunoprecipitate the anti-BLM antibody or anti-TOP2A antibody and the associated proteins; goat IgG was used as an isotype-matched negative control. Immunoprecipitated proteins were separated on a 8% SDS-PAGE and detected by western blotting using either anti-BLM or anti-TOP2A antibody as indicated.
Micronuclei analysis
) were transfected with Effectene (Qiagen) and cultured for 30-h post-transfection with 5 lg/ml cytochalasin B (Sigma). At 48-h post-transfection, cells were fixed in 4% paraformaldehyde, permeabilized in 0.25% Triton-X-100 in PBS and washed before blocking in 10% normal goat serum. Subsequent staining used 1: 800 anti b-tubulin (Novus) in 1% BSA/0.1% Tween/PBS. Cells were mounted with VectaShield DAPI mounting medium (Vector Labs) onto glass sides (Fisher). Cells were imaged using a Zeiss AxioVert 200M with an attached AxioCam MRm camera. One hundred GFP-positive cells from three independent and blinded experiments were counted for micronuclei. Significance of the micronuclei assays was analysed by ANOVA by comparing each treatment group to the control. p-values < 0.05 were considered significant.
UFB analysis
GM08505 cells (BLM
À/À
) or VA13 cells (BLM þ/þ ) were transfected with Effectene (Qiagen) and cultured for 24 h. Cells were then treated with 0.1 mg/ml nocodazole (Sigma) for 3 h and incubated in fresh medium for 1 h. Cells were fixed in 4% paraformaldehyde for 15 min at room temperature, permeabilized in 0.25% Triton-X-100 in PBS and washed before blocking in 10% normal goat serum. Subsequent staining used the indicated antibodies in 1% BSA/0.1% Tween/PBS: 1: 1000 anti-GFP (Abcam 290) overnight. Primary antibodies were visualized with fluorescent AlexaFluor (Invitrogen) secondary antibodies. Cells were mounted with VectaShield DAPI mounting medium (Vector Labs) onto glass sides (Fisher) and imaged using a Zeiss AxioVert 200M with an attached AxioCam MRm camera or Olympus Fluoview 1200 with FV-OSRASW software for confocal images. Fifty GFP-positive cells each from each of two independent and blinded experiments were counted. Data were analysed using Student's t-test; p-values < 0.05 were considered significant.
Cell cycle synchronization and co-localization studies
Cell cycle synchronization used a double-thymidine block and harvest post-release to obtain cells in S-or G 2 /M-phases. GM08505 cells (BLM À/À ) were cultured with 2 mM thymidine (Sigma) for 18 h, washed with PBS and released in fresh media for 9 h; cells were treated a second time with 2 mM thymidine (Sigma) for 17 h. Cells were then washed with PBS and collected at 4 h for G1/S-phase or 11 h for G2/M-phase. Synchronization was confirmed via flow cytometry. Once confirmed, colocalization studies were performed side-by-side. Cells in M-phase were collected following treatment with 40 ng/ll colcemid (Sigma) 6 h prior to harvest. FACS analysis confirmed synchronization. GM08505 cells (BLM À/À ) on glass coverslips (Fisher) were washed in PBS and fixed in 4% paraformaldehyde for 15 min at room temperature. Cells were permeabilized in 0.25% Triton-X-100 in PBS and washed before blocking in 10% normal goat serum and subsequent staining with the indicated antibodies in 1% BSA/0.1% Tween/PBS: 1: 1000 anti-B23 (Sigma B0556), 1: 1000 anti-PML (Abcam 53773) or 1: 1500 anti-TOP2A (TopoGen TG2011-1). Cells were washed in 0.1% Tween/PBS; primary antibodies were visualized with fluorescent AlexaFluor (Invitrogen) secondary antibodies. Coverslips were mounted with VectaShield DAPI mounting medium (Vector Labs) onto glass slides (Fisher). Cells were imaged using a Zeiss AxioVert 200M with an attached AxioCam MRm camera. Fifty GFP-positive cells from each of two independent and blinded experiments were counted for co-localization. Data were analysed using Student's t-test; p-values < 0.05 were considered significant.
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